Recursion Pharmaceuticals: Artificial Intelligence, Real Disappointment

Recursion Pharmaceuticals, Inc. is rated a Sell due to cash burn, Q3 net loss of $162.25M and operational trends. Learn more ...
Morningstar

Rallybio Sells Interest in REV102 Program to Recursion Pharmaceuticals

– Company Eligible to Receive Up to $25 Million, Including an Upfront Equity Payment of $7.5 Million – – Extends Rallybio Cash Runway to Mid-2027 – Rallybio Corporation (Nasdaq: RLYB), a ...
TheServerSide

Example Java String palindrome checker program using recursion

Community driven content discussing all aspects of software development from DevOps to design patterns. Good programmers need to create code that efficiently solves problems, using various methods. A ...
Investing

Rallybio sells HPP treatment program to Recursion for up to $25 million

The program originated from a joint venture between the two companies that combined Rallybio’s expertise in HPP research with Recursion’s AI platform. Under the agreement, Rallybio will also receive ...
Ars Technica

Fibonacci program in assembly with one recursive call

I am working on a project for my assembly language programming class and the prof has us writing a program to calculate fibonacci numbers but we need to make only 1 recursive call. Here is my ...
Investing

Recursion stock target cut to $8 by BofA on pipeline shifts

On Tuesday, BofA Securities revised the price target for Recursion Pharmaceuticals (NASDAQ:RXRX) to $8.00 from the previous $10.00, while keeping a Neutral rating on the company’s shares. The stock ...
Investing

Recursion stock target cut to $8 by BofA on pipeline shifts

Recursion’s current cash reserves amount to $509 million, which is expected to fund operations into mid-2027. InvestingPro analysis shows the company maintains a strong current ratio of 4.11, with ...